Annette E. Sköld

602 total citations
16 papers, 470 citations indexed

About

Annette E. Sköld is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Annette E. Sköld has authored 16 papers receiving a total of 470 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 4 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Annette E. Sköld's work include Immunotherapy and Immune Responses (12 papers), Immune Cell Function and Interaction (10 papers) and Immune Response and Inflammation (5 papers). Annette E. Sköld is often cited by papers focused on Immunotherapy and Immune Responses (12 papers), Immune Cell Function and Interaction (10 papers) and Immune Response and Inflammation (5 papers). Annette E. Sköld collaborates with scholars based in Sweden, Netherlands and United Kingdom. Annette E. Sköld's co-authors include I. Jolanda M. de Vries, Ghaith Bakdash, Gerty Schreibelt, Jasper J. P. van Beek, Anna‐Lena Spetz, Jurjen Tel, Stanleyson V. Hato, Simone P. Sittig, Venkatramanan Mohanram and Sushil Kumar Pathak and has published in prestigious journals such as Journal of Biological Chemistry, Blood and The Journal of Immunology.

In The Last Decade

Annette E. Sköld

16 papers receiving 461 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Annette E. Sköld Sweden 12 391 144 138 39 35 16 470
Adam Giermasz United States 7 554 1.4× 143 1.0× 98 0.7× 25 0.6× 33 0.9× 8 611
John K. Northrop United States 5 456 1.2× 100 0.7× 90 0.7× 23 0.6× 39 1.1× 6 546
Angelika Schlamp Germany 7 384 1.0× 104 0.7× 149 1.1× 19 0.5× 29 0.8× 9 482
Marine de Marcken United States 4 383 1.0× 132 0.9× 100 0.7× 18 0.5× 50 1.4× 5 485
Jack Pengfei Tang United States 4 242 0.6× 258 1.8× 153 1.1× 32 0.8× 27 0.8× 8 434
Mazal Elnekave Israel 8 364 0.9× 110 0.8× 105 0.8× 14 0.4× 35 1.0× 10 451
Monica Montes United States 7 320 0.8× 73 0.5× 93 0.7× 21 0.5× 40 1.1× 7 358
Tanya O. Robinson United States 7 169 0.4× 99 0.7× 67 0.5× 32 0.8× 29 0.8× 16 278
Katherine K. Wynn Australia 10 434 1.1× 200 1.4× 132 1.0× 21 0.5× 93 2.7× 11 523
Catharina Arnold‐Schrauf Germany 13 539 1.4× 140 1.0× 138 1.0× 9 0.2× 77 2.2× 14 658

Countries citing papers authored by Annette E. Sköld

Since Specialization
Citations

This map shows the geographic impact of Annette E. Sköld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annette E. Sköld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annette E. Sköld more than expected).

Fields of papers citing papers by Annette E. Sköld

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annette E. Sköld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annette E. Sköld. The network helps show where Annette E. Sköld may publish in the future.

Co-authorship network of co-authors of Annette E. Sköld

This figure shows the co-authorship network connecting the top 25 collaborators of Annette E. Sköld. A scholar is included among the top collaborators of Annette E. Sköld based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annette E. Sköld. Annette E. Sköld is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Sköld, Annette E., et al.. (2023). A PDGFRB- and CD40-targeting bispecific AffiMab induces stroma-targeted immune cell activation. mAbs. 15(1). 2223750–2223750. 8 indexed citations
2.
Sköld, Annette E., Till S. M. Mathan, Jasper J. P. van Beek, et al.. (2018). Naturally produced type I IFNs enhance human myeloid dendritic cell maturation and IL-12p70 production and mediate elevated effector functions in innate and adaptive immune cells. Cancer Immunology Immunotherapy. 67(9). 1425–1436. 15 indexed citations
3.
Järver, Peter, Candice Poux, AnnSofi Sandberg, et al.. (2018). Single-Stranded Nucleic Acids Regulate TLR3/4/7 Activation through Interference with Clathrin-Mediated Endocytosis. Scientific Reports. 8(1). 15841–15841. 14 indexed citations
4.
Mathan, Till S. M., Johannes Textor, Annette E. Sköld, et al.. (2017). Harnessing RNA sequencing for global, unbiased evaluation of two new adjuvants for dendritic-cell immunotherapy. Oncotarget. 8(12). 19879–19893. 11 indexed citations
5.
Bakdash, Ghaith, Sonja I. Buschow, Mark A.J. Gorris, et al.. (2016). Expansion of a BDCA1+CD14+ Myeloid Cell Population in Melanoma Patients May Attenuate the Efficacy of Dendritic Cell Vaccines. Cancer Research. 76(15). 4332–4346. 90 indexed citations
6.
Mathan, Till S. M., Thien‐Phong Vu Manh, Shivakumar Keerthikumar, et al.. (2016). Proteomics of Human Dendritic Cell Subsets Reveals Subset-Specific Surface Markers and Differential Inflammasome Function. Cell Reports. 16(11). 2953–2966. 55 indexed citations
7.
Bakdash, Ghaith, Jorieke Weiden, Annette E. Sköld, et al.. (2016). A Comparative Study of the T Cell Stimulatory and Polarizing Capacity of Human Primary Blood Dendritic Cell Subsets. Mediators of Inflammation. 2016. 1–11. 55 indexed citations
8.
Beek, Jasper J. P. van, Mark A.J. Gorris, Annette E. Sköld, et al.. (2016). Human blood myeloid and plasmacytoid dendritic cells cross activate each other and synergize in inducing NK cell cytotoxicity. OncoImmunology. 5(10). e1227902–e1227902. 24 indexed citations
9.
Sköld, Annette E., Jasper J. P. van Beek, Simone P. Sittig, et al.. (2015). Protamine-stabilized RNA as an ex vivo stimulant of primary human dendritic cell subsets. Cancer Immunology Immunotherapy. 64(11). 1461–1473. 39 indexed citations
10.
Kreutz, Martin, Ghaith Bakdash, Yusuf Dölen, et al.. (2015). Type I IFN‐mediated synergistic activation of mouse and human DC subsets by TLR agonists. European Journal of Immunology. 45(10). 2798–2809. 18 indexed citations
11.
Beek, Jasper J. P. van, Florian Wimmers, Stanleyson V. Hato, I. Jolanda M. de Vries, & Annette E. Sköld. (2014). Dendritic Cell Cross Talk with Innate and Innate-like Effector Cells in Antitumor Immunity: Implications for DC Vaccination. Critical Reviews in Immunology. 34(6). 517–536. 39 indexed citations
12.
Mohanram, Venkatramanan, Annette E. Sköld, Susanna M. Bächle, Sushil Kumar Pathak, & Anna‐Lena Spetz. (2013). IFN-α Induces APOBEC3G, F, and A in Immature Dendritic Cells and Limits HIV-1 Spread to CD4+ T Cells. The Journal of Immunology. 190(7). 3346–3353. 36 indexed citations
13.
Ruffin, Nicolas, Zelda Euler, Fabio Fiorino, et al.. (2012). Rational design of HIV vaccines and microbicides: report of the EUROPRISE annual conference 2011. Journal of Translational Medicine. 10(1). 5 indexed citations
14.
15.
Sköld, Annette E., Maroof Hasan, Leonardo Vargas, et al.. (2012). Single-stranded DNA oligonucleotides inhibit TLR3-mediated responses in human monocyte-derived dendritic cells and in vivo in cynomolgus macaques. Blood. 120(4). 768–777. 24 indexed citations
16.
Mohanram, Venkatramanan, Ulrika Johansson, Annette E. Sköld, et al.. (2011). Exposure to Apoptotic Activated CD4+ T Cells Induces Maturation and APOBEC3G- Mediated Inhibition of HIV-1 Infection in Dendritic Cells. PLoS ONE. 6(6). e21171–e21171. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Adam Giermasz Breakdown of academic impact, for papers by John K. Northrop Breakdown of academic impact, for papers by Angelika Schlamp Breakdown of academic impact, for papers by Marine de Marcken Breakdown of academic impact, for papers by Jack Pengfei Tang Breakdown of academic impact, for papers by Mazal Elnekave Breakdown of academic impact, for papers by Monica Montes Breakdown of academic impact, for papers by Tanya O. Robinson Breakdown of academic impact, for papers by Katherine K. Wynn Breakdown of academic impact, for papers by Catharina Arnold‐Schrauf
Rankless by CCL
2026